Anticoagulation for critically ill cardiac surgery patients: Is primary bivalirudin the next step?

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 28, Issue 4, 2014, Pages 1013-1017

  Pappalardo, Federico ^a   Agracheva, Nataliya ^a   Covello, Remo Daniel ^a   Pieri, Marina ^a   De Bonis, Michele ^a   Calabrò, Maria Grazia ^a   Koster, Andreas ^b   Zangrillo, Alberto ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

bivalirudin; cardiac surgery; heparin; heparin induced thrombocytopenia; mortality

Indexed keywords

HEPARIN; HIRULOG; ANTITHROMBIN; HIRUDIN DERIVATIVE; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ADULT; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DRUG USE; FEMALE; HEART SURGERY; HUMAN; INTENSIVE CARE UNIT; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; CRITICAL ILLNESS; DOSE RESPONSE; EPIDEMIOLOGY; FOLLOW UP; INTRAVENOUS DRUG ADMINISTRATION; ITALY; POSTOPERATIVE COMPLICATIONS; PROPENSITY SCORE; RETROSPECTIVE STUDY; SURVIVAL RATE; THROMBOSIS; TRENDS;

ANTITHROMBINS; CARDIAC SURGICAL PROCEDURES; CRITICAL ILLNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HIRUDINS; HUMANS; INJECTIONS, INTRAVENOUS; ITALY; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; POSTOPERATIVE COMPLICATIONS; PROPENSITY SCORE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SURVIVAL RATE; THROMBOSIS;

EID: 84905756766     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2013.10.004     Document Type: Article

References (29)

1. V. Trehel-Tursis, V. Louvain-Quintard, and Y. Zarrouki et al. Clinical and biological features of patients suspected or confirmed to have heparin-induced thrombocytopenia in a cardiothoracic surgical ICU Chest 142 2012 837 844
2. L.J. Demma, A.M. Winkler, and J.H. Levy A diagnosis of heparin induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients Anesth Analg 113 2011 697 702
3. E.M. Crespo, G.B.F. Oliveira, and E.F. Honeycut et al. Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications after Thrombocytopenia Caused by heparin (CATCH) registry Am Heart J 157 2009 651 657
4. J.G. Augoustides Update in hematology: Heparin-induced thrombocytopenia and bivalirudin J Cardiothorac Vasc Anesth 25 2011 371 375
5. G. Patti, V. Pasceri, and L. D'Antonio et al. Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in high-risk patients undergoing percutaneous coronary intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin study) Am J Cardiol 110 2012 478 484
6. A. Kastrati, F.J. Neumann, and S. Schulz et al. ISAR-REACT 4 Trial Investigators. Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction N Engl J Med 365 2011 1980 1989
7. S. Bangalore, D.J. Cohen, and N.S. Kleiman et al. EVENT Registry Investigators, Boston, MA. Bleeding risk comparing targeted low-dose heparin with bivalirudin in patients undergoing percutaneous coronary intervention: Results from a propensity score-matched analysis of the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry Circ Cardiovasc Interv 4 2011 463 473
8. J. Wöhrle, N. Merkle, and M. Kunze et al. Effect of bivalirudin compared with unfractionated heparin plus abciximab on infarct size and myocardial recovery after primary percutaneous coronary intervention: The horizons-AMI CMRI substudy Catheter Cardiovasc Interv 79 2012 1083 1089
9. A.M. Lincoff, J.A. Bittl, and N.S. Kleiman et al. Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial) Am J Cardiol 93 2004 1092 1096
10. A.M. Lincoff, J.A. Bittl, and R.A. Harrington et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial JAMA 289 2003 853 863
11. V.D. Vidi, M.E. Matheny, and V. Agarwal et al. Validation of long-term benefits of bivalirudin versus unfractionated heparin in routine clinical practice after percutaneous coronary intervention Am J Cardiol 106 2010 1234 1240
12. M. Thielmann, M. Bunschkowski, and P. Tossios et al. Perioperative thrombocytopenia in cardiac surgical patients - Incidence of heparin-induced thrombocytopenia, morbidities and mortality Eur J Cardiothorac Surg 37 2009 1391 1395
13. A. Kuitunen, R. Suojaranta-Ylinen, and P. Raivio et al. Heparin-induced thrombocytopenia following cardiac surgery is associated with poor outcome J Cardiothorac Vasc Anesth 21 2007 18 22
14. A. Assman, I.J. Boeken, and P. Feindl et al. Heparin-induced thrombocytopenia type II after cardiac surgery: Predictors and outcome Thorac Cardiovasc Surg 58 2010 463 467
15. F. Pappalardo, G. Maj, and A. Scandroglio et al. Bioline heparin-coated ECMO with bivalirudin anticoagulation in a patient with acute heparin-induced thrombocytopenia: The immune reaction appeared to continue unabated Perfusion 24 2009 135 137
16. M. Ranucci, A. Ballotta, and H. Kandil et al. Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation Crit Care 15 2011 R275
17. T.E. Warkentin, A. Greinacher, and A. Koster Heparin-induced thrombocytopenia in patients with ventricular assist devices: Are new prevention strategies required? Ann Thorac Surg 87 2009 1633 1640
18. F. Pappalardo, A.M. Scandroglio, and E. Potapov et al. Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices Minerva Anestesiol 78 2012 330 335
19. S. Selleng, Malowsky, and U. Strobel et al. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive J Thromb Haemost 8 2010 30 36
20. L.A. Linkins, A.L. Dans, and L.K. Moores et al. American College of Chest Physicians. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e495S e4530S
21. E. Young, M. Prins, and M.N. Levine et al. Heparin binding to plasma proteins, an important mechanism for heparin resistance Thromb Haemost 67 1992 639 643
22. T. Barzu, P. Molho, and G. Tobelem et al. Binding and endocytosis of heparin by human endothelial cells in culture Biochim Biophys Acta 845 1985 196 203
23. M. Ranucci, G. Isgrò, and A. Cazzaniga et al. Predictors for heparin resistance in patients undergoing coronary artery bypass grafting Perfusion 14 1999 437 442
24. S.X. Anand, M.C. Kim, and M. Kamran et al. Comparison of platelet function and morphology in patients undergoing percutaneous coronary intervention receiving bivalirudin versus unfractionated heparin versus clopidogrel pretreatment and bivalirudin Am J Cardiol 100 2007 417 424
25. N.J. Mutch, L.A. Robbie, and N.A. Booth Human thrombi contain an abundance of active thrombin Thromb Haemost 86 2001 1028 1034
26. J.I. Weitz, M. Hudoba, and D. Massel et al. Clot bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors J Clin Invest 86 1990 385 391
27. S.X. Anand, J.F. Viles-Gonzalez, and S.K. Mahboobi et al. Bivalirudin utilization in cardiac surgery: Shifting anticoagulation from indirect to direct thrombin inhibition Can J Anaesth 58 2011 296 311
28. M. Pieri, N. Agracheva, and E. Bonaveglio et al. Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: A case-control study J Cardiothorac Vasc Anest 27 2013 30 34
29. A.J. Rastan, N. Lachman, and T. Walther et al. Autopsy findings in patients on postcardiotomy extracorporeal membrane oxygenation (ECMO) Int J Artif Organs 29 2006 1121 1131